Axonics announces cfo retirement and appoints successor

Irvine, calif.--(business wire)--axonics, inc. (nasdaq: axnx), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that dan l. dearen, president and chief financial officer, is retiring from the company. kari keese, vice president of finance and accounting, will succeed mr. dearen on monday, october 2. “on behalf of the axonics team and the board of directors, i want to thank dan, my co-fou.
AXNX Ratings Summary
AXNX Quant Ranking